medrysone (hms) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Medrysone is a synthetic glucocorticoid used to to treat inflammatory eye diseases such as allergic conjunctivitis, vernal conjunctivitis, and episcleritis.   NCATS

Chemistry

  • SMILES: C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14
  • InChIKey: GZENKSODFLBBHQ-ILSZZQPISA-N
  • Mol. Mass: 344.4877
  • ALogP: 3.94
  • ChEMBL Molecule:
    medrysone  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Topical
  • Pro Drug: No

Alternative names

11beta-hydroxy-6alpha-methylpregn-4-ene-3,20-dione | 11-hydroxy-6-methylprogesterone | hms | hms liquifilm | hms suspension | hydroxymesterone | medrifar | medrocort | medrysone | u-8471

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (3)


 

Conjunctivitis (approved 1969)

Conjunctivitis, Allergic (approved 1969)

Scleritis (approved 1969)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue